Member Info for Winstanley

This is purely speculation, but based on the information available, it is possible that GlaxoSmithKline (GSK) may be involved with the discovery mentioned in the BBC article. MIT has established connections with GlaxoSmithKline (GSK) through various collaborative efforts. GSK operates a research facility in Technology Square, Cambridge, Massachusetts, which is adjacent to MIT. This facility focuses on oncology, human genetics, artificial intelligence, and functional genomics. The proximity allows for direct collaboration between GSK scientists and MIT researchers.

Nothing is confirmed, we mere mortals can only guess:

https://www.bbc.co.uk/news/articles/cgr94xxye2lo

Https://www.lse.co.uk/news/london-close-stocks-edge-higher-on-hopes-of-fed-rate-cut-x3cjw5bazmbiheo.html

It appears there was some confusion regarding the timing of the Federal Reserve's announcements. The Federal Reserve is indeed scheduled to make an announcement today, August 13, 2025, at 19:00 GMT. However, this announcement is not expected to include a rate cut decision. Instead, it is likely to provide insights or updates regarding the current economic conditions and the Fed's monetary policy outlook. Does anyone know when we will get clarity?

The Federal Reserve's interest rate decision is expected to be announced today, August 13, 2025, at 19:00 GMT. US Treasury Secretary Scott Bessent said that there is a good chance that the Fed could opt for a 50 basis points rate cut.

Https://www.pharmaceutical-technology.com/news/eli-lilly-and-gsk-drive-south-koreas-drug-licensing-activity/?cf-view

Nice start to the morning - on the rise.

Https://www.manchester.ac.uk/about/news/how-rfk-jr-is-systematically-undermining-vaccines-around-the-world/

Https://pharmaphorum.com/news/fda-starts-swift-review-gsk-antibiotic-gonorrhoea

Https://www.thisismoney.co.uk/money/markets/article-14984145/Drugmaker-GSK-lands-372m-Covid-jab-pact.html

There certainly doesn't seem to be any logic in the way it's going!

Sprint,

The settlement is a strategic resolution to patent disputes.

From the other side:

https://investors.biontech.de/news-releases/news-release-details/biontech-reaches-agreement-receive-non-exclusive-license-mrna

Https://uk.finance.yahoo.com/news/market-wrong-pharmaceutical-company-prospects-040000988.html

GSK has reached a significant settlement regarding mRNA patent litigation with CureVac and BioNTech, resulting in an 'upfront' payment of $370 million - and a '1% royalty' on future U.S. sales of mRNA vaccines developed by Pfizer and BioNTech. This agreement not only provides GSK with immediate financial benefits but also positions the company to earn ongoing revenue from the booming mRNA vaccine market, which has seen substantial growth due to the COVID-19 pandemic. The expected revenue from this settlement is noteworthy, as it could lead to millions in royalties over time, especially with the increasing demand for mRNA vaccines for both COVID-19 and influenza. Overall, this settlement enhances GSK's financial outlook and reinforces its strategic position in the rapidly evolving biopharmaceutical landscape.

https://www.gsk.com/en-gb/media/press-releases/gsk-provides-update-on-us-settlement-of-curevacbiontech-mrna-patent-litigation/

One wonders, how many CEOs are treading carefully in autocrat land?

Trump is known for targeting business leaders with public criticism to a degree unheard of with other presidents:

https://www.bbc.co.uk/news/articles/c70x6602pdyo

The-Lockie,

It might be a hold and wait situation. In my opinion, predicting Trump's moves is a unique skill akin to psycho-anyalising, but GSK's fundamentals remain robust; the dividend is healthy, and there is noticeable increasing dissatisfaction with the current U.S. administration. The Epstein scandal could potentially be the tipping point!

The-Lockie,

It might be a hold and wait situation. In my opinion, predicting Trump's moves is a unique skill akin to psycho-anyalising, but GSK's fundamentals remain robust; the dividend is healthy, and there is noticeable increasing dissatisfaction with the current U.S. administration. The Epstein scandal could potentially be the tipping point!

Done some shopping today - anyone else brave enough?

Trump sent letters to 17 major pharmaceutical companies demanding that they reduce drug prices for Americans by September 29, 2025 and tamped up the rhetoric today (hense the price drop). The letters outline specific actions the companies must take, in Trump's mind, to align U.S. drug prices with the lowest prices offered in other developed nations, a policy known as the most-favored-nation (MFN) pricing.

Will the pharmaceutical company allow this guy to dictate? If they do the U.S.. autocrat will just be starting:

https://www.msn.com/en-us/money/markets/donald-trump-threatens-250-tariff-on-pharmaceuticals/ar-AA1K27GA

Remember, Trump is known as TACO, and for good reason.

There no telling where the loon will lead us (possibly even war!) - but do you feel lucky ?